The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.
In the face of an opioid overdose crisis, President Biden oversaw a historic shift toward harm reduction for addiction.
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...
As opioid pain medications continue being prescribed for chronic and severe pain, understanding their risks becomes increasingly crucial. While these pills may offer temporary relief, their ...
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for adults experiencing moderate to severe acute pain. Journavx received FDA ...